https://www.seppalalab.org/tag/funding/FundingHugo Blox Builder (https://hugoblox.com)enThu, 15 May 2025 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pnghttps://www.seppalalab.org/tag/funding/https://www.seppalalab.org/post/2026-lynch-syndrome-funding/Thu, 15 May 2025 00:00:00 +0000https://www.seppalalab.org/post/2026-lynch-syndrome-funding/<p>Seppälä Lab has received EUR 13.6 million in funding to advance early detection of Lynch syndrome-associated cancers. Lynch syndrome is one of the most common hereditary cancer predisposition syndromes, significantly increasing lifetime risk of colorectal, endometrial, and other cancers.</p> <p>This funding will support development of novel screening approaches and biomarkers aimed at earlier, more accurate detection — improving outcomes for Lynch syndrome carriers and their families.</p> <p><a href="https://www.tuni.fi/en/tau/news-and-events/eur13-6-million-funding-early-detection-lynch-syndrome-cancers" target="_blank" rel="noopener">Read the full news article at Tampere University →</a></p>https://www.seppalalab.org/post/2025-cancer-foundation-funding/Tue, 06 May 2025 00:00:00 +0000https://www.seppalalab.org/post/2025-cancer-foundation-funding/<p>Cancer Foundation Finland (Syöpäsäätiö) has awarded Toni Seppälä a EUR 150,000 grant to support a two-year patient study aimed at optimizing colorectal cancer treatment using modern methods.</p> <p>The study will use tumor DNA analysis from blood samples to identify effective and safe treatment combinations for individual patients, with a focus on colorectal cancer subtypes that respond to immunotherapy.</p> <p><a href="https://syopasaatio.fi/huippututkija-tutkimus-tuo-toivoa/" target="_blank" rel="noopener">Read the full article at Syöpäsäätiö →</a></p>